GenomeNet

Database: UniProt
Entry: CCNE_CAEEL
LinkDB: CCNE_CAEEL
Original site: CCNE_CAEEL 
ID   CCNE_CAEEL              Reviewed;         524 AA.
AC   O01501; O77098; Q86FL2;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   27-MAR-2024, entry version 161.
DE   RecName: Full=G1/S-specific cyclin-E;
GN   Name=cye-1 {ECO:0000312|WormBase:C37A2.4a};
GN   ORFNames=C37A2.4 {ECO:0000312|WormBase:C37A2.4a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=12606285; DOI=10.1016/s0012-1606(02)00032-5;
RA   Brodigan T.M., Liu J., Park M., Kipreos E.T., Krause M.;
RT   "Cyclin E expression during development in Caenorhabditis elegans.";
RL   Dev. Biol. 254:102-115(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10952902; DOI=10.1242/dev.127.18.4049;
RA   Fay D.S., Han M.;
RT   "Mutations in cye-1, a Caenorhabditis elegans cyclin E homolog, reveal
RT   coordination between cell-cycle control and vulval development.";
RL   Development 127:4049-4060(2000).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17115027; DOI=10.1038/ncb1511;
RA   Cowan C.R., Hyman A.A.;
RT   "Cyclin E-Cdk2 temporally regulates centrosome assembly and establishment
RT   of polarity in Caenorhabditis elegans embryos.";
RL   Nat. Cell Biol. 8:1441-1447(2006).
RN   [5]
RP   FUNCTION.
RX   PubMed=17466069; DOI=10.1186/1471-213x-7-38;
RA   Ouellet J., Roy R.;
RT   "The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle
RT   transition in C. elegans.";
RL   BMC Dev. Biol. 7:38-38(2007).
RN   [6]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=17476329; DOI=10.1371/journal.pone.0000407;
RA   Fujita M., Takeshita H., Sawa H.;
RT   "Cyclin E and CDK2 repress the terminal differentiation of quiescent cells
RT   after asymmetric division in C. elegans.";
RL   PLoS ONE 2:E407-E407(2007).
RN   [7]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=19758560; DOI=10.1016/j.devcel.2009.08.003;
RA   Biedermann B., Wright J., Senften M., Kalchhauser I., Sarathy G., Lee M.H.,
RA   Ciosk R.;
RT   "Translational repression of cyclin E prevents precocious mitosis and
RT   embryonic gene activation during C. elegans meiosis.";
RL   Dev. Cell 17:355-364(2009).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20005870; DOI=10.1016/j.ydbio.2009.12.005;
RA   Inoue T., Sternberg P.W.;
RT   "C. elegans BED domain transcription factor BED-3 controls lineage-specific
RT   cell proliferation during organogenesis.";
RL   Dev. Biol. 338:226-236(2010).
RN   [9]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=21558371; DOI=10.1242/dev.059535;
RA   Fox P.M., Vought V.E., Hanazawa M., Lee M.H., Maine E.M., Schedl T.;
RT   "Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle
RT   progression in the C. elegans germline.";
RL   Development 138:2223-2234(2011).
RN   [10]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=21455289; DOI=10.1371/journal.pgen.1001348;
RA   Jeong J., Verheyden J.M., Kimble J.;
RT   "Cyclin E and Cdk2 control GLD-1, the mitosis/meiosis decision, and
RT   germline stem cells in Caenorhabditis elegans.";
RL   PLoS Genet. 7:E1001348-E1001348(2011).
CC   -!- FUNCTION: Essential for the control of the cell cycle at the G1/S
CC       (start) transition (PubMed:12606285). In association with cdk-2,
CC       regulates proliferation, quiescent state and cell fate during the
CC       development of several cell lineages (PubMed:10952902, PubMed:17476329,
CC       PubMed:21558371, PubMed:21455289). In the embryo, initiates the
CC       establishment of cell polarity through the recruitment of the
CC       centrosomal proteins spd-2 and spd-5 during prophase (PubMed:17115027).
CC       During the development of the vulva, controls the onset of vulval cell
CC       terminal differentiation by controlling the duration of G1 phase
CC       (PubMed:10952902, PubMed:20005870). During hypoderm development at
CC       early larval stages, controls syncytial fate of seam cell daughter
CC       cells (PubMed:17476329). Involved in the progression of cell division
CC       in the intestinal lineage in larvae, and in particular in
CC       endoreplication, a specific growth pathway in the intestinal
CC       epithelium, required for feeding and gut development in growing larvae
CC       (PubMed:17466069). By controlling the activity of translational
CC       repressor gld-1, regulates the pool of germline stem cells and the size
CC       of the mitotic zone by preventing entry into meiosis (PubMed:21455289).
CC       In addition, repression of expression by gld-1 prevents mitosis re-
CC       entry in meiotic germline cells (PubMed:19758560).
CC       {ECO:0000269|PubMed:10952902, ECO:0000269|PubMed:12606285,
CC       ECO:0000269|PubMed:17115027, ECO:0000269|PubMed:17466069,
CC       ECO:0000269|PubMed:17476329, ECO:0000269|PubMed:19758560,
CC       ECO:0000269|PubMed:20005870, ECO:0000269|PubMed:21455289,
CC       ECO:0000269|PubMed:21558371}.
CC   -!- SUBUNIT: Interacts with a member of the CDK2/CDK protein kinases to
CC       form a serine/threonine kinase holoenzyme complex. The cyclin subunit
CC       imparts substrate specificity to the complex (By similarity).
CC       {ECO:0000250|UniProtKB:P24864}.
CC   -!- INTERACTION:
CC       O01501; O61847: cdk-2; NbExp=3; IntAct=EBI-6499833, EBI-14063070;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12606285}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:17115027}. Note=Co-localizes with cdk-2 in the
CC       sperm centrioles before the first embryonic mitosis and then to the
CC       male and female nuclei upon entry into mitosis.
CC       {ECO:0000269|PubMed:12606285, ECO:0000269|PubMed:17115027}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a {ECO:0000269|PubMed:12606285};
CC         IsoId=O01501-1; Sequence=Displayed;
CC       Name=b {ECO:0000269|PubMed:12606285};
CC         IsoId=O01501-2; Sequence=VSP_007909;
CC   -!- TISSUE SPECIFICITY: Expressed dynamically in proliferating cells
CC       throughout development. Detectable in larval blast cells undergoing
CC       active proliferation that give rise to all tissue types, including
CC       germline, intestine, hypodermis, neurons, and muscle.
CC       {ECO:0000269|PubMed:12606285}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Ubiquitous embryonic pattern of expression declines during
CC       embryogenesis and disappears from most cells in comma-stage embryos
CC       coincident with the completion of the majority of embryonic cell
CC       divisions. Expression levels drop and become restricted and dynamic
CC       during postembryonic development (PubMed:12606285). During the
CC       development of distal tip cells, expressed asymmetrically between the
CC       daughters of the Z1.a and Z4.p cells; asymmetric expression is
CC       regulated by wrm-1, a component of the Wnt/MAPK pathway
CC       (PubMed:17476329). In the gonads, expression is restricted to the
CC       proliferating distal germline cells (PubMed:12606285, PubMed:21558371).
CC       In germline cells entering meiosis, expression is repressed by gld-1
CC       (PubMed:21455289, PubMed:19758560). {ECO:0000269|PubMed:12606285,
CC       ECO:0000269|PubMed:17476329, ECO:0000269|PubMed:19758560,
CC       ECO:0000269|PubMed:21455289, ECO:0000269|PubMed:21558371}.
CC   -!- DISRUPTION PHENOTYPE: Loss of cell division in vulval lineages as a
CC       result of lengthened intervals between cell divisons (PubMed:20005870).
CC       RNAi-mediated knockdown results in arrest prior to the 100-cell
CC       embryonic stage (PubMed:10952902). Depending on the knockdown, some
CC       animals reach adult age (PubMed:17476329). In the 1-cell embryo,
CC       persistent ruffling throughout the embryo cortex and mislocalization of
CC       par-2, which remains cytoplasmic, and par-6, which is distributed
CC       throughout the cortex. In 50 percent of embryos, the first division is
CC       symmetric. Adult mutants are sterile due to a lack of sperm and egg
CC       production (PubMed:17115027). In mutants and knockdown animals,
CC       production of 2 additional distal tip cells (DTC) is often associated
CC       with the production of an extra gonad (PubMed:17476329). In addition,
CC       gonads of knockdown animals have an abnormal mitotic zone characterized
CC       by an enlargement of the distal germ cell nuclei, a reduction in the
CC       number of mitotic germ cells, a reduction in the mitotic region length
CC       and an abnormal expression of gld-1 (PubMed:21455289).
CC       {ECO:0000269|PubMed:10952902, ECO:0000269|PubMed:17115027,
CC       ECO:0000269|PubMed:17476329, ECO:0000269|PubMed:20005870,
CC       ECO:0000269|PubMed:21455289}.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin E subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF520616; AAM78547.1; -; mRNA.
DR   EMBL; AF058331; AAC63505.1; -; mRNA.
DR   EMBL; FO080805; CCD66921.1; -; Genomic_DNA.
DR   EMBL; FO080805; CCD66922.1; -; Genomic_DNA.
DR   PIR; T43050; T43050.
DR   RefSeq; NP_001021027.1; NM_001025856.3. [O01501-1]
DR   RefSeq; NP_001021028.1; NM_001025857.2. [O01501-2]
DR   AlphaFoldDB; O01501; -.
DR   SMR; O01501; -.
DR   BioGRID; 37847; 22.
DR   ComplexPortal; CPX-1127; Cyclin cye-1-cdk2 complex.
DR   IntAct; O01501; 7.
DR   STRING; 6239.C37A2.4a.1; -.
DR   EPD; O01501; -.
DR   PaxDb; 6239-C37A2-4a; -.
DR   PeptideAtlas; O01501; -.
DR   EnsemblMetazoa; C37A2.4a.1; C37A2.4a.1; WBGene00000871. [O01501-1]
DR   EnsemblMetazoa; C37A2.4b.1; C37A2.4b.1; WBGene00000871. [O01501-2]
DR   GeneID; 172399; -.
DR   KEGG; cel:CELE_C37A2.4; -.
DR   UCSC; C37A2.4a; c. elegans. [O01501-1]
DR   AGR; WB:WBGene00000871; -.
DR   WormBase; C37A2.4a; CE24832; WBGene00000871; cye-1. [O01501-1]
DR   WormBase; C37A2.4b; CE33761; WBGene00000871; cye-1. [O01501-2]
DR   eggNOG; KOG0655; Eukaryota.
DR   GeneTree; ENSGT00940000169122; -.
DR   InParanoid; O01501; -.
DR   OMA; CESEKLH; -.
DR   OrthoDB; 5474295at2759; -.
DR   PhylomeDB; O01501; -.
DR   Reactome; R-CEL-1538133; G0 and Early G1.
DR   Reactome; R-CEL-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-CEL-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-CEL-6804116; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest.
DR   Reactome; R-CEL-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-CEL-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.
DR   Reactome; R-CEL-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-CEL-69563; p53-Dependent G1 DNA Damage Response.
DR   Reactome; R-CEL-8849470; PTK6 Regulates Cell Cycle.
DR   PRO; PR:O01501; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00000871; Expressed in adult organism and 4 other cell types or tissues.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005813; C:centrosome; IBA:GO_Central.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0097134; C:cyclin E1-CDK2 complex; IPI:ComplexPortal.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; ISS:WormBase.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0042023; P:DNA endoreduplication; IMP:WormBase.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0007281; P:germ cell development; IMP:WormBase.
DR   GO; GO:0051729; P:germline cell cycle switching, mitotic to meiotic cell cycle; IMP:WormBase.
DR   GO; GO:0008406; P:gonad development; IGI:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:WormBase.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IGI:WormBase.
DR   GO; GO:1904781; P:positive regulation of protein localization to centrosome; IGI:UniProtKB.
DR   GO; GO:0040026; P:positive regulation of vulval development; IMP:WormBase.
DR   GO; GO:0009791; P:post-embryonic development; IMP:WormBase.
DR   GO; GO:0010608; P:post-transcriptional regulation of gene expression; IMP:WormBase.
DR   GO; GO:0051445; P:regulation of meiotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IDA:UniProtKB.
DR   GO; GO:1904776; P:regulation of protein localization to cell cortex; IMP:UniProtKB.
DR   CDD; cd20519; CYCLIN_CCNE_rpt1; 1.
DR   CDD; cd20520; CYCLIN_CCNE_rpt2; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 2.
DR   InterPro; IPR039361; Cyclin.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR048258; Cyclins_cyclin-box.
DR   PANTHER; PTHR10177; CYCLINS; 1.
DR   PANTHER; PTHR10177:SF344; G1_S-SPECIFIC CYCLIN-E; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 2.
DR   PROSITE; PS00292; CYCLINS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Cyclin; Cytoplasm;
KW   Cytoskeleton; Meiosis; Mitosis; Nucleus; Reference proteome.
FT   CHAIN           1..524
FT                   /note="G1/S-specific cyclin-E"
FT                   /id="PRO_0000080458"
FT   REGION          1..155
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        14..41
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        45..62
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        63..104
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        105..121
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        128..155
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         100..102
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000303|PubMed:12606285"
FT                   /id="VSP_007909"
SQ   SEQUENCE   524 AA;  60586 MW;  5B16BA7E70AA5F15 CRC64;
     MAGRKSSRTA ERVPTTQKPE RKSAILSPHD ELRERLLETA IDMKENIPQR NTRNSSVGSQ
     KSDCSETRKR RSTKEGPAAK RHSGEKHRNG SREDSLEYIS EYSDDREVGS SSSQSSRTRG
     QPLPAMPEEE EVFDKSSSSD NLAESEESHE MVRLEERQDI EEEIEDDFDD EEEDVVNDKE
     EYEEIESEDE DDYPVQNEGF AVTKRLMNDE HMVTAPTFLS TAKCDGIGSP TKVWSLMVKR
     DEIPRATRFL LGNHPDMDDE KRRILIDWMM EVCESEKLHR ETFHLAVDYV DRYLESSNVE
     CSTDNFQLVG TAALFIAAKY EEIYPPKCID FAHLTDSAFT CDNIRTMEVL IVKYIGWSLG
     PITSIQWLST YLQLLGTGKK NKSDHYEEQN MYVPELLRSE YLEMCKILDF LLFEIDSFTF
     SYRTIAAAVL FVNYEPTCAV EKATGFMQAQ LEKVIEYVEP VCRAFAKQRQ LLDDVIPKHE
     SIKSDDSHNI QVYVKRSSME PIVKSERERI QHLKARRLHP QRLF
//
DBGET integrated database retrieval system